Literature DB >> 10891399

A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines.

D L Crowe1, T N Brown, R Kim, S M Smith, M K Lee.   

Abstract

c-fos is the prototypic member of a family of transcription factors that regulate many cellular processes, including proliferation. c-fos heterodimerizes with jun family members to form the AP-1 transcription factor complex which binds specific DNA recognition elements in the promoters of many genes. Following rapid induction in response to serum or growth factors, c-fos regulates expression of downstream target genes involved in cellular proliferation. Although much work has focused on activation of cell cycle regulatory genes by c-fos, less is known about negative regulation of gene expression by this transcription factor. The cyclin-dependent kinase (cdk) inhibitor p21(Cip1/WAF1) is a negative regulator of cdk activity, thereby impeding cell cycle progression. By sequence analysis, we identified a putative AP-1 element in the p21(Cip1/WAF1) promoter. To investigate how this site regulated p21(Cip1/WAF1) expression and mitigate external effects on c-fos expression, we used a c-fos/estrogen receptor (c-fosER) fusion construct in which this transcription factor is conditionally activated by estradiol. In the presence of estradiol, c-fosER downregulated p21(Cip1/WAF1) promoter activity. This inhibition was dependent on the putative AP-1 site. Activation of c-fosER induced cell cycle progression and proliferation in a manner similar to serum stimulation. We concluded that activation of c-fosER mediated transcriptional inhibition of p21(Cip1/WAF1) through a previously uncharacterized AP-1 site, revealing an important role for c-fos in negative control of cell cycle regulatory genes. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891399     DOI: 10.1006/mcbr.2000.0221

Source DB:  PubMed          Journal:  Mol Cell Biol Res Commun        ISSN: 1522-4724


  8 in total

1.  Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest.

Authors:  Drew Burdon; Rajnikant Patel; R A John Challiss; Jonathan L Blank
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

2.  Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin E kinase complexes.

Authors:  R F Hennigan; P J Stambrook
Journal:  Mol Biol Cell       Date:  2001-08       Impact factor: 4.138

3.  Adhesion of different cell cycle human hepatoma cells to endothelial cells and roles of integrin beta1.

Authors:  Guan-Bin Song; Jian Qin; Qing Luo; Xiao-Dong Shen; Run-Bin Yan; Shao-Xi Cai
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

4.  The FOS transcription factor family differentially controls trophoblast migration and invasion.

Authors:  Stephen J Renaud; Kaiyu Kubota; M A Karim Rumi; Michael J Soares
Journal:  J Biol Chem       Date:  2013-12-30       Impact factor: 5.157

5.  c-fos gene and protein expression in pelvic endometriosis: a local marker of estrogen action.

Authors:  Debora M Morsch; Marcia M Carneiro; Sheila B Lecke; Fabiano C Araújo; Aroldo F Camargos; Fernando M Reis; Poli Mara Spritzer
Journal:  J Mol Histol       Date:  2009-02-08       Impact factor: 2.611

6.  DNA Microarray Analysis of Estrogen Responsive Genes in Ishikawa Cells by Glabridin.

Authors:  Poh Su Wei Melissa; Yong Voon Chen Phelim; Visweswaran Navaratnam; Chia Yoke Yin
Journal:  Biochem Insights       Date:  2017-07-26

7.  Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer.

Authors:  Shilpi Gupta; Prabhat Kumar; Harsimrut Kaur; Nishi Sharma; Daman Saluja; Alok C Bharti; Bhudev C Das
Journal:  Sci Rep       Date:  2015-11-19       Impact factor: 4.379

8.  Apurinic/apyrimidinic endonuclease/redox effector factor-1(APE/Ref-1): a unique target for the prevention and treatment of human melanoma.

Authors:  Sun Yang; Frank L Meyskens
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.